Search

everythinglearnresearchcommunity

for

Search:↓

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

Wnt signaling is important for development and cell regulation but can cause diseases like cancer when not working properly.

Indian Gooseberry has potential for cancer prevention and treatment and promotes hair growth.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

Aesthetic treatments can safely improve cancer patients' quality of life with oncologist approval.

Cedrol may be an effective treatment for colorectal cancer.

Plant-based compounds may offer safer prostate cancer treatment with fewer side effects.

Finasteride lowers prostate cancer risk but may increase high-grade tumors and sexual side effects.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Oral minoxidil effectively improves hair regrowth in cancer survivors with late alopecia.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Dihydrotestosterone increases growth and spread of human brain cancer cells, and blocking its formation might help treat this cancer.

People with denser forearm hair have a higher risk of certain skin cancers.

New inhibitors may reduce gut toxicity from cancer drugs.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

Cancer patients, especially with blood cancers, face severe COVID-19 risks due to weakened immunity.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Prostate cancer is common, but risk can be reduced by avoiding smoking, unhealthy diet, inactivity, certain medications, and risky jobs.

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

Colorectal cancer development involves both genetic changes and epigenetic alterations like DNA methylation and microRNA changes.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Finasteride may improve prostate cancer treatment outcomes.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

New treatments like nanotechnology show promise in improving skin cancer therapy.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.